For sales

Highlights from the Week of 23rd March 2026- 30th March 2026 in the world of pharma and healthcare

Highlights from the week of 23rd March - 30th March Rocket Pharma ( FDA, Approval ) Rocket Pharma obtains FDA approval for KRESLADI, an autologous hematopoietic stem cell-based gene therapy to treat pediatric patients with severe leukocyte adhesion deficiency-I Denali Therapeutics ( FDA, Approval ) FDA grants approval to Denali Therapeutics' AVLAYAH, an enzyme replacement therapy to treat the neurologic manifestations of Hunter syndrome Corcept Therapeutics ( FDA, Approval ) Corcept Therapeutics gets FDA approval for LIFYORLI plus nab-paclitaxel to treat platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received prior systemic treatment regimens Gedeon Richter ( EU, Approval ) EC grants approval to Gedeon Richter's FYLREVY as a hormone replacement therapy for oestrogen deficiency symptoms in non-hysterectomised postmenopausal women All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.